Revenue

Intuit's QuickBooks will exclusively integrate Affirm's BNPL, letting SMBs get paid upfront while customers pay over time to fix cash flow issues.

Go inside Power Digital's strategy, where employee empowerment, proprietary AI, and strategic acquisitions have earned it a top spot on Ad Age's list.

A new PropTech firm is challenging automated home estimates with bestimation™, an expert-audited valuation designed to give homeowners 'Truth Data'.

Following strong Texas sales, cbdMD brings its Herbal Oasis THC seltzer to Louisiana, betting on a market eager for functional alcohol alternatives.

A major private equity investment in The Forge Companies signals a shift toward integrated financial planning for a complex and fragmented settlement market.

A new report warns one in five malware infections will expose corporate logins by late 2026 as attackers pivot to high-value enterprise identity platforms.

From automated bookings to data-driven operations, a new tech tide is rising, promising greater efficiency for operators and better experiences for boaters.

With its largest fund yet, the firm is doubling down on breakthrough biotech and medtech, signaling strong investor faith in deep science innovation.

With a massive new investment, CyberFOX plans to accelerate AI development and acquisitions, aiming to reshape the security landscape for underserved MSPs.

A new deal with Sourcewell lets Alliant streamline insurance for 50,000+ public agencies, cutting red tape and boosting risk management nationwide.

A new liquid biopsy more accurately predicts cancer recurrence than standard methods, offering new hope and clarity for patients after surgery.

vTv Therapeutics shores up its finances with a deal worth up to $135M, sharpening its focus on a breakthrough Type 1 diabetes drug, cadisegliatin.

A new AI embedded in smart meters detects grid faults in real time, promising to stop wildfires and power outages before they start. Here's how it works.

At MD&M West 2026, Boyd showcases how materials science and regulatory expertise are the unsung heroes behind the next wave of medical wearables.

The firm's strategic relocation to an amenity-rich retail hub signals deep confidence in the Sunbelt and a new vision for the modern corporate office.

Ensem Therapeutics expands its global trial for ETX-636, a next-gen cancer drug designed to avoid common toxicities, into China's vast patient market.

The acquisition expands Connect Media beyond its real estate stronghold, creating a diversified giant in the competitive B2B information and events market.

With a major Phase 3 trial now in Europe, Crystalys Therapeutics aims to fill a critical gap in gout care with a drug already proven in Asian markets.

Gen II Fund Services unveils its AI-powered Sensr Portal, promising to transform private market data access from static reports to conversational insights.

Automotive giant Garrett Motion enters the HVAC market with oil-free tech, promising major energy savings and a greener future for commercial buildings.